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ABSTRACT
Objective amyotrophic lateral sclerosis (aLs) is 
a neurodegenerative disease of the motor system. 
The split hand sign in aLs refers to observed 
preferential weakness of the lateral hand muscles, 
which is unexplained. One possibility is larger cortical 
representation of the lateral hand compared with the 
medial. Biceps strength is usually preserved relative to 
triceps in neurological conditions, but biceps has a larger 
cortical representation and might be expected to show 
preferential weakness in aLs.
Methods Using the south-east england Register 
for amyotrophic Lateral sclerosis, we performed a 
retrospective longitudinal cohort study and extracted 
the modified Medical Research council (MRc) muscle 
strength score for biceps and triceps in patients with a 
diagnosis of upper limb-onset aLs in the 19-year period 
1996–2015. a Wilcoxon signed-rank test was used to 
assess the relative strength of the muscles within the 
total sum of the upper limbs involved in the study.
Results There were 659 people with upper limb onset 
of weakness. In 215 there were insufficient data to 
perform the analysis, and a further 33 were excluded 
for other reasons, leaving 411 for analysis. Biceps 
was stronger than triceps in 87 limbs, and triceps was 
stronger than biceps in 258 limbs, with no difference 
seen in the remaining 477. Triceps strength scores (mean 
rank=186.1) were higher than ipsilateral biceps strength 
scores (mean rank=134.2), Z=−10.1, p<0.001 (two-
tailed).
Conclusion Triceps strength is relatively preserved 
compared with biceps in aLs. This is consistent with a 
broadly corticofugal hypothesis of selective vulnerability, 
in which susceptibility might be associated with larger 
cortical representation.
INTROduCTION
Amyotrophic lateral sclerosis (ALS) is a neurode-
generative syndrome of the upper and lower motor 
neurons (and their wider cortical networks) char-
acterised by relentlessly progressive skeletal muscle 
paralysis that ultimately leads to respiratory failure 
and death.1 The site of onset of clinical symptoms 
and their spread in ALS are non-random, but within 
a strikingly heterogeneous clinical syndrome that 
is currently unified by the postmortem identifica-
tion of neuronal and glial cytoplasmic inclusions 
of Trans-Activating Response (TAR) DNA-Binding 
Protein-43 (TDP-43).
A well-recognised clinical phenomenon in ALS 
is the split hand sign, broadly characterised as 
preferential wasting and weakness of the thenar 
muscles, with relative sparing of the hypothenar 
muscles.2 More specifically, the sign is demon-
strated by dominant wasting of the abductor pollicis 
brevis and the first dorsal interosseous on the lateral 
aspect of the hand, with sparing of the abductor 
digiti minimi on the medial aspect, resulting in the 
split phenomenon.3 4 This pattern of involvement 
is surprising, since isolated median nerve damage 
would not affect the first dorsal interosseous, ulnar 
nerve damage would not affect the thenar eminence 
yet should involve abductor digiti minimi, and 
root pathology would cause wasting of the thenar, 
hypothenar and interosseous muscles. Thus, the 
pattern cannot be explained by a lesion of the ulnar 
nerve, median nerve or root. One explanation for 
this phenomenon is that it reflects cerebral somato-
topic hand representation, which is larger for the 
lateral hand for primates, in line with the evolution 
of fine motor control.5 6 The split hand would then 
reflect a greater vulnerability correlated to the size 
of the cortical map, supporting a broader concept 
of a corticofugal mode of neurodegeneration in 
ALS.7 8
A similar phenomenon exists at the level of the 
lower limbs in patients with ALS, characterised 
by preferential wasting of the ankle plantar flexor 
muscles compared with the dorsiflexors, resulting 
in a ‘split leg’ pattern.9 Although the ankle dorsi-
flexors receive a greater density of corticomoto-
neuronal projections than the plantar flexors, the 
nature of these projections with inhibitory cortical 
modulation being greater in the latter may help 
elucidate the pathogenesis in ALS in keeping with 
the hypothesis of altered inhibitory interneuronal 
function.10
A so-called pyramidal distribution of weakness 
is associated with lesions of the motor pathway 
anywhere from the cortex to the neuromuscular 
junction, whereby flexors dominate extensors 
in the upper limbs, and vice versa in the lower 
limbs. The elbow exhibits a degree of physio-
logical flexion at rest, which is readily appreci-
ated through the exaggeration that follows the 
maturation of a contralateral hemispheric stroke. 
However, the cortical representation of biceps is 
greater than that of triceps.11 For ALS, therefore, 
in keeping with the split hand and the split leg, one 
would expect biceps brachii to become preferen-
tially involved reflecting its larger cortical repre-
sentation. We therefore tested this hypothesis by 
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Figure 1 Flow chart illustrating the selection of eligible patients for 
the study. aLs, amyotrophic lateral sclerosis; MND, motor neuron disease; 
seaLs, south-east england Register for amyotrophic Lateral sclerosis.
examining the relative strength of biceps and triceps muscles in 
people with ALS.
MeThOdS
Patient data
Data were gathered from the South-East England Register for 
Amyotrophic Lateral Sclerosis (SEALS). This population-based 
register was established in 1997 and captures every person 
with ALS within a defined geographical region including Kent 
and South East London.12 To ensure involvement of the upper 
limbs, we selected all patients with upper limb-onset ALS and 
used Medical Research Council (MRC) motor strength scores 
for elbow flexion with the arm fully supinated (biceps) and 
elbow extension (triceps) recorded at the first visit to the tertiary 
referral clinic. The MRC system grades muscle strength as 0 (no 
movement at all), 1 (a flicker of movement), 2 (movement of the 
limb, but not able to lift its own weight), 3 (limb able to lift its 
own weight but not against resistance), 4 (reduced power against 
resistance) and 5 (full power). Grade 4 is further subdivided into 
4− (barely able to resist), 4 (weak) and 4+ (only a little weak-
ness). We noted handedness and converted the modified MRC 
score given for each muscle to a scaled score of 0–7; MRC scores 
of 0, 1, 2, 3, 4−, 4, 4+ and 5 were mapped to the scores 0, 1, 2, 
3, 4, 5, 6 and 7, respectively.
Statistical analysis
As MRC scores are not normally distributed, the Wilcoxon 
signed-rank test was used to compare biceps power with triceps 
power in the same limb. Each limb was considered independently 
and not paired within the same individual. A sensitivity analysis 
was performed by excluding limbs in which both muscles had 
full power.
The binomial test of proportions was used to test whether 
differential strength patterns in one limb affected the probability 
of a similar observation in the other limb, and to test the degree 
of concordance between handedness and differential strength 
patterns.
The power function of the Wilcoxon signed-rank test is diffi-
cult to define.13 Using the exact variance approach, there is 80% 
power to detect a difference of 10% between biceps and triceps 
scores in a sample size of n=419, where n is the total number 
of upper limbs.
Data were entered into a spreadsheet, and calculations were 
performed using Excel and IBM Statistics SPSS V.24.
ReSulTS
In the SEALS register, there were 659 people recorded as having 
upper limb-onset ALS in the 19-year period from January 1996 
to November 2015 (figure 1 shows a Consolidated Standards of 
Reporting Trials diagram). Detailed health records were missing 
for 215. Two people presenting with fasciculations or sensory 
symptoms in the absence of weakness were excluded. Review of 
the health records showed that 18 people in fact had lower limb 
onset and 7 had bulbar onset. Those with comorbidities that 
could influence MRC scores were removed from the subsequent 
analysis; these included spinal cord transection, polymicrogyria, 
peripheral neuropathy of undetermined cause, stroke, systemic 
lupus erythematosus and capsulitis. A total of 411 people and 
822 upper limb score sets were therefore available for study.
The mean age of onset was 57 years (SD 13) and 74% were 
male. There was no difference in age with respect to gender. The 
initial upper limb weakness was right-sided in 41%, left-sided in 
39%, bilateral in 19% and missing in 1%. There were 128 (31%) 
people previously or currently on riluzole. Eighty-five per cent 
were right-handed, 8% left-handed and 2% ambidextrous, with 
7% missing handedness data.
Biceps was stronger than triceps in 87 limbs, triceps stronger 
than biceps in 258 limbs, and 477 limbs had equal scores. Overall, 
triceps was stronger than biceps (triceps mean rank 186.1, biceps 
mean rank 134.2; Z −10.1, p=8.5×10−24 [two-tailed]). The 
median triceps score was 6 (IQR 5–7) and the mean was 5.69 
(SD 1.5, 95% CI 5.59 to 5.79), while the median biceps score 
was 6 (IQR 4–7) and the mean was 5.27 (SD 1.83, 95% CI 5.13 
to 5.39). Frequencies for each score are shown in figure 2.
Limbs were analysed independently of the patient. This 
approach assumes that the pattern of weakness on one side 
is independent of the pattern of weakness on the other in the 
same person. We therefore tested this assumption. There were 
88 people with concordant findings of stronger triceps in both 
limbs, and 82 with discordant findings in which only one limb 
showed the stronger triceps pattern. Assuming that it is equally 
likely that biceps or triceps will be stronger, a binomial test has 
p=0.701 (two-tailed), suggesting that the presence of the sign 
on one side does not influence its occurrence in the contralateral 
upper limb.
Of the 477 limbs with equal scores, 265 had full power. 
Repeating the analysis with these limbs excluded made no differ-
ence to the findings.
We explored the effect of handedness on the findings. Of the 
258 limbs with triceps stronger than biceps, there was missing 
information on handedness for 15 limbs, leaving 243 for study. 
Of these, 78 had one side with triceps stronger and therefore 
available for analysis. There was no concordance between hand-
edness and the side of stronger triceps: 45 concordant of 78 
(58%), p=0.213 (two-tailed).
dISCuSSION
We have shown that, on average, triceps is stronger than biceps 
in upper limb-onset ALS, contrary to the classical so-called pyra-
midal pattern of weakness. If, as suggested in relation to the split 
hand and split leg phenomena, the explanation is that greater 
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Figure 2 Bar charts indicating the frequency of scores for each limb on 
the 8-point grading system for both biceps and triceps.
cortical representation of one set of muscles versus another 
makes the motor neurons more vulnerable to degeneration, then 
the study lends support to the broader concept of a cortically 
based process, and therefore a ‘split elbow’.
Our sample was typical of other similar samples, with 74% 
male as expected for spinal-onset ALS.14 Symptom onset in the 
limbs is usually asymmetrical, with the onset of weakness more 
frequently occurring in the dominant upper limb.15 16 While 
we reproduced that finding here, where the upper limbs were 
discordant for the split elbow, it was not more frequent on the 
dominant side.
The triceps muscles are innervated by the radial nerve, while 
the biceps muscles receive innervation from the musculocuta-
neous nerve; both nerves branch from the brachial plexus, which 
is collectively formed by the nerve roots C5–T1.17 In healthy 
individuals, the elbow flexors are stronger than the extensors, 
with average elbow flexion strength being 70.8 Nm in men and 
39.3 Nm in women, and extension strength being 33.6 Nm in 
men and 19.3 Nm in women.18 A reduction in both flexion and 
extension by 30% is necessary to assess for a pyramidal distribu-
tion of weakness,19 and we would therefore expect that biceps 
would, on average, be stronger than triceps in ALS.
Attempts to distil the increasing complexity of the clinicopath-
ological syndrome of ALS into either a peripheral ‘dying back’ 
or a central ‘dying forward’ process continue.7 20 Transcranial 
magnetic stimulation studies have shown hyperexcitability of 
the cortex as a perisymptomatic feature of ALS,21 22 and dying 
forward would mean that areas with higher cortical represen-
tation might be involved preferentially in neurodegeneration. 
Comparative observations of deep tendon reflexes between 
pairs of muscles might provide further support for a corticofugal 
pattern of degeneration. In this context, it is interesting that 
bulbar-onset ALS is characterised by preferential wasting of 
the tongue compared with other oropharyngeal muscles, as the 
tongue receives greater cortical innervation.23
Our study has limitations. Not all those identified as eligible 
for the study could be included because of missing health 
records, which will introduce bias into the study. The modified 
MRC score is vulnerable to differences in inter-rater and intr-
arater reliability, as well as intersubject variability.24 25 All our 
measurements were made by four specialists in ALS, trained by 
a single person, which would to some extent mitigate this issue, 
but a more objective measure of strength such as dynamometry 
would be ideal.26–28 This study is cross-sectional and therefore 
susceptible to the bias of prevalent, younger populations that 
attend clinic that is not present in population-based studies. It 
may be that the phenomenon observed is more likely to be seen 
in younger people, for example, and is not a general feature of 
ALS.
Replication of our findings in other cohorts is needed. The 
split hand phenomenon has been studied electrophysiologically 
to demonstrate its sensitivity and specificity as an early diag-
nostic tool, and similar studies would be important for the split 
elbow sign.29 Transcranial magnetic stimulation studies can serve 
as an objective assessment of upper motor neuron involvement 
in ALS and therefore cortical dysfunction, as has been shown 
with the split hand phenomenon,30 31 providing support for the 
hypothesis of a corticofugal mode of degeneration. Limiting the 
study by disease stage might also be useful because information 
is only available when there is some weakness but not complete 
weakness.32 33
The pattern of preferential weakness of triceps versus biceps 
we have found supports the broader concept of ALS as a neuro-
degenerative disease with a cortically defined pathogenesis.
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